UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2016

Commission Filing Number: 001-33751

CHINA NEPSTAR CHAIN DRUGSTORE LTD.

(Translation of registrant’s name into English)

25F, Neptunus Yinhe Keji Building

No.1, Kejizhong 3rd Road, Nanshan District

Shenzhen, Guangdong Province 518057

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes ¨ No x

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes ¨ No x

EXHIBIT INDEX

Number		Description of Document
99.1		Press Release
99.2		Agreement and Plan of Merger, dated as of March 16, 2016, by and among China Neptunus Drugstore Holding Ltd., Neptunus Global Limited and China Nepstar Chain Drugstore Ltd.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CHINA NEPSTAR CHAIN DRUGSTORE LTD.


	By:	/s/ Zixin Shao
	Name: Zixin Shao
	Title: Chief Financial Officer

Date: March 1629, 2016

Filing Compare · China Nepstar Chain Drugstore Ltd.